OmniActive Health eyes more takeovers, to invest Rs 150 crore

Published On 2017-11-13 08:33 GMT   |   Update On 2021-08-18 08:28 GMT

New Delhi: OmniActive Health Technologies, a leading nutraceutical company, is looking at more strategic acquisitions in domestic and foreign markets and has drawn up capital expenditure plans of around Rs 150 crore in the next three years.


Building on an M&A (mergers and acquisitions) strategy to grow inorganically, the company has recently acquired leading health and nutrition active natural ingredient player, Indfrag.


"We are now looking at more strategic acquisitions in the domestic as well as foreign markets in the space of marketing and technology," OmniActive MD Sanjaya Mariwala told here.


The company's strength lies in its ability to leverage science and technology to meet consumer demand and rigorous quality standards for today's dietary supplement market.


In the last 18 months, OmniActive completed 12 human clinical trials with healthy population across its portfolio of branded ingredients, providing unique, science-based claims to expand consumer offerings.


"We are continuously making the investment in R&D and expansion programmes. We are doing a capex of Rs 30-35 crore per annum and going forward, looking at the investment of around Rs 150 crore for expansion of more nutraceutical products," Mariwala said.


The company hopes to double its turnover to Rs 1,000 crore in three years, he said.


The Mumbai-based OmniActive supplies ingredients to several global clients, including large healthcare, nutrition, and consumer staples companies. It has the presence in six countries -- the US, Canada, the UK, France, China, and Japan.


With state of the art R&D centers in Pune, Mumbai and New Jersey, OmniActive deploy an array of sophisticated manufacturing technologies in extraction, purification, isolation, and delivery of nutritional actives.


The company is looking at launching more supplement products for the population of 30-45 years of age group and women.


The country's nutraceutical market is estimated at USD 500-600 million and is growing 15-20 percent on a CAGR (compound annual growth rate) basis.


With the recent acquisition of Indfrag, OmniActive is now set to launch a new business venture in the v-commerce domain that aims to provide products to the Internet-savvy younger group, Mariwala added.


Virtual commerce, or v-commerce, is a kind of application, service, or product feature that helps entities execute strategies and design websites for e-commerce.

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News